RVMD

Revolution Medicines, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$99.12

Market Cap

$19.64B

Beta

1.01

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-66.20%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-4.65%

Debt / Equity0.10

Interest Coverage-50.6x

No credit card required

Already have an account? Sign in to view the full analysis for RVMD.